<?xml version="1.0" encoding="UTF-8"?><own:edgarSubmission xmlns:com="http://www.sec.gov/edgar/common" xmlns:own="http://www.sec.gov/edgar/ownership">
  <!-- Generated by Workiva -->
  <own:headerData>
    <own:submissionType>144</own:submissionType>
    <own:filerInfo>
      <own:filer>
        <own:filerCredentials>
          <own:cik>0002113223</own:cik>
          <own:ccc>XXXXXXXX</own:ccc>
        </own:filerCredentials>
      </own:filer>
      <own:liveTestFlag>LIVE</own:liveTestFlag>



    </own:filerInfo>
  </own:headerData>
  <own:formData>
    <own:issuerInfo>
      <own:issuerCik>0001889109</own:issuerCik>
      <own:issuerName>Belite Bio, Inc.</own:issuerName>
      <own:secFileNumber>001-41359</own:secFileNumber>
      <own:issuerAddress>
        <com:street1>12750 High Bluff Drive</com:street1>
        <com:street2>Suite 475</com:street2>
        <com:city>San Diego</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>92130</com:zipCode>
      </own:issuerAddress>
      <own:issuerContactPhone>858-246-6240</own:issuerContactPhone>
      <own:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Hendrik Peter Scholl</own:nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <own:relationshipsToIssuer>
        <own:relationshipToIssuer>Officer</own:relationshipToIssuer>
      </own:relationshipsToIssuer>
    </own:issuerInfo>
    <own:securitiesInformation>
      <own:securitiesClassTitle>American Depositary Shares, each representing one ordinary share</own:securitiesClassTitle>
      <own:brokerOrMarketmakerDetails>
        <own:name>J.P. Morgan Securities LLC</own:name>
        <own:address>
          <com:street1>270 Park Avenue, 10th Floor</com:street1>
          <com:city>New York</com:city>
          <com:stateOrCountry>NY</com:stateOrCountry>
          <com:zipCode>10017</com:zipCode>
        </own:address>
      </own:brokerOrMarketmakerDetails>
      <own:noOfUnitsSold>4000</own:noOfUnitsSold>
      <own:aggregateMarketValue>679280</own:aggregateMarketValue>
      <own:noOfUnitsOutstanding>39339960</own:noOfUnitsOutstanding>
      <own:approxSaleDate>10/01/2026</own:approxSaleDate>
      <own:securitiesExchangeName>NASDAQ</own:securitiesExchangeName>
    </own:securitiesInformation>
    <own:securitiesToBeSold>
      <own:securitiesClassTitle>American Depositary Shares, each representing one ordinary share</own:securitiesClassTitle>
      <own:acquiredDate>10/08/2025</own:acquiredDate>
      <own:natureOfAcquisitionTransaction>RSU Vesting</own:natureOfAcquisitionTransaction>
      <own:nameOfPersonfromWhomAcquired>Issuer</own:nameOfPersonfromWhomAcquired>
      <own:isGiftTransaction>N</own:isGiftTransaction>
      <own:amountOfSecuritiesAcquired>4000</own:amountOfSecuritiesAcquired>
      <own:paymentDate>10/08/2025</own:paymentDate>
      <own:natureOfPayment>Compensation</own:natureOfPayment>
    </own:securitiesToBeSold>
    <own:nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</own:nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <own:remarks>The shares covered by this filing will be sold by Bioptima AG, Hendrik Peter Scholl as Director.  The shares will be sold today or within three months from the date of this filing.</own:remarks>
    <own:noticeSignature>
      <own:noticeDate>10/01/2026</own:noticeDate>
      <own:planAdoptionDates>
        <own:planAdoptionDate>06/25/2026</own:planAdoptionDate>
      </own:planAdoptionDates>
      <own:signature>/s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Hendrik Peter Scholl</own:signature>
    </own:noticeSignature>
  </own:formData>
</own:edgarSubmission>
